Loading…
Delcath Systems, Inc. is projected to rise to $16.17 by 2027, a +32% move from its current price of $12.22. DCTH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $11.98 | $12.22 | $12.47 | +0.02% |
| Aug 4 | $11.88 | $12.22 | $12.58 | +0.04% |
| Aug 5 | $11.80 | $12.23 | $12.67 | +0.06% |
| Aug 6 | $11.74 | $12.23 | $12.74 | +0.08% |
| Aug 7 | $11.69 | $12.23 | $12.80 | +0.10% |
| Aug 8 | $11.64 | $12.23 | $12.86 | +0.12% |
| Aug 9 | $11.59 | $12.24 | $12.92 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $11.59 | $12.24 | $12.92 | +0.14% |
| Week 2 | $11.35 | $12.25 | $13.23 | +0.27% |
| Week 3 | $11.17 | $12.27 | $13.47 | +0.41% |
| Week 4 | $11.03 | $12.29 | $13.69 | +0.55% |
| Week 5 | $10.90 | $12.30 | $13.88 | +0.68% |
| Week 6 | $10.79 | $12.32 | $14.07 | +0.82% |
| Week 7 | $10.69 | $12.34 | $14.23 | +0.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers in the United States and Europe. Its lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe.
The company was founded in 1988 and is headquartered in Queensbury, New York.
Delcath Systems, Inc. (DCTH) currently trades at $11.94 per share and has a market capitalization of $412.19M. Its rank among listed assets is 3045.
The near-term outlook for the stock shows a neutral trajectory in 2026, with a forecast average price of $11.94, a low of $8.60, and a high of $14.80, and a 0% ROI.
From 2027 onward, the forecast depicts bullish momentum with rising average prices and sizable ROIs, culminating in a 2050 average price of $149.82 and an ROI of 1154.8%. The outlook includes a sequence of year-by-year gains, with notable milestones at 2030 ($25.67 avg, ROI 115%) and 2040 ($64.85 avg, ROI 443.1%).
A major floor 27.3% below — a decisive break under it would weaken the trend.
The nearest floor, 5.8% below — buyers have tended to step in here.
The nearest ceiling, 10.6% above — a clean break opens room to run.
A major ceiling 18.1% above — clearing it would confirm fresh momentum.
Key DCTH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DCTH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.87 | Buy | $12.04 | Buy |
| MA 10 | $12.19 | Buy | $12.18 | Buy |
| MA 20 | $12.67 | Sell | $12.34 | Sell |
| MA 50 | $12.01 | Buy | $12.04 | Buy |
| MA 100 | $11.14 | Buy | $11.48 | Buy |
| MA 200 | $10.47 | Buy | $11.10 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.43 | Neutral |
| Stoch RSI (14) | 49.71 | Neutral |
| CCI (20) | -60.74 | Neutral |
| Williams %R (14) | -58.90 | Info |
| MACD (12,26,9) | -0.15 | Sell |
| ROC (12) | -7.28 | Sell |
| Bollinger %B (20,2) | 0.31 | Neutral |
| Stochastic %K (14) | 41.10 | Neutral |
| TRIX (15) | 0.09 | Buy |
| Awesome (5,34) | -0.63 | Sell |
| Ultimate (7,14,28) | 42.28 | Neutral |
| Momentum (10) | -0.59 | Sell |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 11.72 | Buy |
| ADX (14) | 15.69 | Neutral |
| ATR (14) | 0.25 | Info |
The 30-day technical picture shows bullish sentiment overall. RSI14 stands at 40, while the moving averages place the stock near key trend lines: SMA50 at $11.95 and SMA200 at $10.45.
Near-term support is at $11.51 and resistance at $13.52, with a 30-day price range of $10.47 to $13.62. The stock experiences higher volatility, reflected in an annualized volatility of 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.60 | $12.22 | $15.24 | 0% | Neutral | |
| $13.19 | $16.17 | $20.77 | +32% | Bullish | |
| $15.69 | $19.63 | $25.96 | +61% | Bullish | |
| $19.24 | $24.49 | $33.13 | +100% | Bullish | |
| $22.21 | $28.69 | $39.56 | +135% | Bullish | |
| $23.52 | $30.79 | $43.18 | +152% | Bullish | |
| $26.79 | $35.51 | $50.57 | +191% | Bullish | |
| $28.49 | $38.20 | $55.15 | +213% | Bullish | |
| $30.96 | $41.97 | $61.37 | +243% | Bullish | |
| $39.42 | $53.99 | $79.90 | +342% | Bullish | |
| $56.05 | $80.42 | $125.11 | +558% | Bullish | |
| $123.29 | $191.21 | $320.24 | +14.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $8.60 | $12.22 | $14.49 | +0.00% |
| September 2026 | $10.60 | $12.45 | $14.97 | +1.90% |
| October 2026 | $10.54 | $12.44 | $15.08 | -0.11% |
| November 2026 | $10.28 | $12.19 | $14.87 | -2.01% |
| December 2026 | $10.44 | $12.42 | $15.24 | +1.91% |
Click any year to see its month-by-month DCTH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The DCTH price prediction for 2026 points to an average of $12.22 (low $8.60, high $15.24) — a potential gain of 0% on today's $12.22. Price action looks broadly range-bound.
In 2027, DCTH is projected to trade between $13.19 and $20.77, averaging $16.17 — a potential gain of +32% from today's $12.22. That is up +32% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Delcath Systems, Inc.'s 2028 outlook centres on $19.63, within a $15.69 to $25.96 range. That is up +21% on the projected 2027 average. That marks a +61% change versus current levels. Momentum favours further upside here.
By 2029, DCTH could reach as high as $33.13, with a base case around $24.49 and support toward $19.24 — roughly +100% from $12.22. Buyers look set to stay in control over this stretch.
Expect DCTH to range from $22.21 to $39.56 through 2030. The $28.69 average target implies a +135% move from current prices. That is up +17% on the projected 2029 average. Momentum favours further upside here.
The DCTH price prediction for 2031 points to an average of $30.79 (low $23.52, high $43.18) — a potential gain of +152% on today's $12.22. Buyers look set to stay in control over this stretch.
In 2032, DCTH is projected to trade between $26.79 and $50.57, averaging $35.51 — a potential gain of +191% from today's $12.22. That is up +15% on the projected 2031 average. Momentum favours further upside here.
Delcath Systems, Inc.'s 2033 outlook centres on $38.20, within a $28.49 to $55.15 range. That is up +8% on the projected 2032 average. That marks a +213% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, DCTH could reach as high as $61.37, with a base case around $41.97 and support toward $30.96 — roughly +243% from $12.22. Momentum favours further upside here.
Expect DCTH to range from $39.42 to $79.90 through 2035. The $53.99 average target implies a +342% move from current prices. That is up +29% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The DCTH price prediction for 2040 points to an average of $80.42 (low $56.05, high $125.11) — a potential gain of +558% on today's $12.22. Momentum favours further upside here.
In 2050, DCTH is projected to trade between $123.29 and $320.24, averaging $191.21 — a potential gain of +14.6x from today's $12.22. That is up +138% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in DCTH today (≈ 81.833061 DCTH) could be worth
$15,647.56
+$14,647.56 (+1465%) by 2050 · US Dollar
Based on the average projected DCTH price of $191.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DCTHwould be worth at today's price.
$1,000 invested in DCTH on Jul 31, 2025 (≈ 93.023256 DCTH) would be worth
$1,136.74
+$136.74 (+13.7%) today · 1.14× · US Dollar
Based on a DCTH entry price of $10.75 vs. today's $12.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $12.22 | $1,000 | -0.0% |
| 1 month ago | $12.91 | $946.55 | -5.3% |
| 3 months ago | $10.8 | $1,131.48 | +13.1% |
| 6 months ago | $9.98 | $1,224.45 | +22.4% |
| 1 year ago | $10.75 | $1,136.74 | +13.7% |
| All time (5.0y) ago | $9.81 | $1,245.67 | +24.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DCTH forecast.
Our base-case forecast reaches $24.00 around 2029.
Implied market cap at $24.00: $828.52M
The multi-year forecast starts with 2026 having an average price of $11.94 and a 0% ROI, indicating a neutral near-term view.
From 2027 to 2035, the forecast shows a bullish trajectory with steadily higher averages: 2027 $15.23 (ROI 27.6%), 2028 $18.01 (ROI 50.9%), 2029 $22.25 (ROI 86.4%), 2030 $25.67 (ROI 115%), 2031 $27.12 (ROI 127.1%), 2032 $30.95 (ROI 159.2%), 2033 $32.71 (ROI 174%), 2034 $35.34 (ROI 196%), 2035 $45.22 (ROI 278.7%).
Looking further out, 2040 sees an average of $64.85 (ROI 443.1%), and 2050 an average of $149.82 (ROI 1154.8%). The forecast implies significant upside, but it also notes these are estimates, not guarantees, and outcomes depend on market dynamics and execution of the company’s clinical programs.
Tap a question to reveal the answer.
Avg price $25.67, min $19.93, max $35.28; ROI 115%.
Forecasts show bullish sentiment from 2027 onward, with averages rising to $25.67 by 2030 and $149.82 by 2050 and ROIs up to 1154.8%.
Yes—the 2040 forecast max is $100.32; the 2050 max is $249.24.
Current price is $11.94 and market cap is $412.19M.
Sentiment: BULLISH. RSI(14) = 40. SMA50 = $11.95, SMA200 = $10.45. 30-day range: $10.47–$13.62. Support: $11.51. Resistance: $13.52. Annualized volatility: 40%.
Delcath Systems, Inc. Community Discussion
0Share your Delcath Systems, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.